Transfusion in patients with acute major blood loss: Evidence when, for whom and what products are best

EHA Library, JJ Zwaginga, 219152

Update on the pathophysiology and management of acute trauma hemorrhage and trauma-induced coagulopathy

EHA Library, Marc Maegele, 219151

Clinical and laboratory evaluation of acute blood loss and hemorrhagic shock

EHA Library, Augusto Federici, 219150

Potential perils of iron supplementation in low income countries

EHA Library, Andrew Prentice, 219149

Congenital sideroblastic anemia: Iron and heme lost in mitochondrial translation

EHA Library, Mark Fleming, 219148

Iron-sulfur protein biogenesis in health and disease

EHA Library, Roland Lill, 219147

Preventing relapse of transplant

EHA Library, Charles Craddock, 219145

Clinical implications of minimal residual disease

EHA Library, Jan Cornelissen, 219144

Methods to detect minimal residual disease

EHA Library, Torsten Haferlach, 219143

From antibiotics to ibrutinib: An array of treatment modalities

EHA Library, Catherine Thieblemont, 219141

Marginal zone lymphoma: Differentiation among pathologically challenging entities

EHA Library, Maurilio Ponzoni, 219140

Deregulation of cell signaling in marginal zone lymphoma

EHA Library, Ming Qing Du, 219139

Current role of chemotherapy free drug combinations for chronic lymphocytic leukemia

EHA Library, Michael Hallek, 219095

MIR-451 IS A NEW BIOMARKER THAT IDENTIFIES ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS WHO MAY BENEFIT FROM TREATMENT WITH NAMPT INHIBITORS

EHA Library, Keren shichrur, 214664

NOVEL PROGNOSTIC MARKER ARID5B LOW EXPRESSION IN ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Chunhua song, 214665

NOVEL IKAROS TARGET RAG1 HIGH EXPRESSION IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Zheng Ge, 214666

S100A16 INHIBITED PROLIFERATION AND PROMOTED APOPTOSIS THROUGH REGULATION OF ERK PATHWAY IN B CELL ALL

EHA Library, Jing Zhang, 214667

MELATONIN INHIBITS MLL-REARRANGED LEUKEMIA VIA RBFOX3/HTERT AND NF-ΚB/COX-2 SIGNALING PATHWAYS

EHA Library, Yan-Lai Tang, 214668

INVESTIGATING THE SYNERGISM BETWEEN CHK1 AND WEE1 PROTEINS INHIBITION IN THE TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Andrea Ghelli Luserna Di Rora, 214669

AN UPDATED ANALYSIS OF TISAGENLECLEUCEL IN PEDIATRIC/YOUNG ADULT PATIENTS WITH RELAPSED/REFRACTORY (R/R) B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) IN A US MULTICENTER CLINICAL TRIAL (ENSIGN)

EHA Library, Shannon Maude, 214670

PHASE I STUDY OF UCART19, AN ALLOGENEIC ANTI-CD19 CAR T-CELL PRODUCT, IN HIGH RISK PEDIATRIC PATIENTS WITH CD19+ RELAPSED/REFRACTORY (R/R) B-CELL ALL: PRELIMINARY RESULTS OF PALL STUDY

EHA Library, Waseem Qasim, 214671

CHARACTERISTICS AND OUTCOMES OF ADULTS WITH ACUTE LYMPHOBLASTIC LEUKAEMIA RELAPSING POST-ALLOGENEIC HAEMATOPOIETIC CELL TRANSPLANTATION IN THE PROSPECTIVE UKALL14 TRIAL (ISRCTN 665421317).

EHA Library, Anna Castleton, 214672

INOTUZUMAB OZOGAMICIN TREATMENT IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA: ANALYSIS FROM INO-VATE BY BONE MARROW BLAST PERCENTAGE

EHA Library, David Marks, 214673

UCART19, AN ALLOGENEIC ANTI-CD19 CAR T-CELL PRODUCT, IN HIGH RISK ADULT PATIENTS WITH CD19+ RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: PRELIMINARY RESULTS OF PHASE I CALM STUDY

EHA Library, Reuben Benjamin, 214674

LONG-TERM SURVIVAL OF ADULTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (BCP-ALL) AFTER TREATMENT WITH BLINATUMOMAB AND SUBSEQUENT ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Nicola Goekbuget, 214675

RE-THINKING THE PROGNOSTIC RELEVANCE OF A CD20 EXPRESSION CUT-OFF OF 20% IN ACUTE LYMPHOBLASTIC LEUKAEMIA: INITIAL RESULTS FROM THE UKALL14 TRIAL

EHA Library, Katharine Bailey, 214676

IMPROVEMENT OF PATIENT-REPORTED QUALITY OF LIFE FOLLOWING TISAGENLECLEUCEL INFUSION IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Andre Baruchel, 214677

OUTCOMES WITH INOTUZUMAB OZOGAMICIN IN PATIENTS WITH PHILADELPHIA CHROMOSOME–POSITIVE RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Giovanni Martinelli, 214678

IMPACT OF MINIMAL RESIDUAL DISEASE STATUS IN CLINICAL OUTCOMES OF PATIENTS WITH RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH INOTUZUMAB OZOGAMICIN IN THE PHASE 3 INO-VATE TRIAL

EHA Library, Nicola Gökbuget, 214679

EXTENSIVE SAFETY PROFILE OF INOTUZUMAB OZOGAMICIN IN RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS ENROLLED IN THE PHASE 3 INO-VATE TRIAL

EHA Library, Daniel DeAngelo, 214680

BLINATUMOMAB AND TYROSINE KINASE INHIBITORS COMBINATION IN RELAPSED/REFRACTORY ACUTE LYMPHOBALTIC LEUKEMIA: PRIMARY RESULTS AND LATE EVENTS

EHA Library, Andrey Sokolov, 214681

CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY IN PEDIATRIC/ADOLESCENT/YOUNG ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA IN FIRST RELAPSE AFTER ALLOGENEIC STEM CELL TRANSPLANT IN CR1

EHA Library, Peter Bader, 214682

INDIRECT TREATMENT COMPARISON OF BLINATUMOMAB VS INOTUZUMAB OZOGAMICIN FOR TREATING ADULT PATIENTS WITH RELAPSED OR REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA RECEIVING ZERO OR ONE PRIOR SALVAGE THERAPY

EHA Library, Ze Cong, 214683

LONG TERM OUTCOME OF 138 ALO TRANSPLANTS IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA ON A SINGLE TRANSPLANT CENTER IN SPAIN

EHA Library, Irati Ormazabal Velez, 214684

ROBUST IN VIVO SYNERGY BETWEEN THE ANTI-CD33 ADC, IMGN779 AND THE FLT3 INHIBITOR QUIZARTINIB IN HUMAN FLT3-ITD AML MODELS.

EHA Library, Krystal Watkins, 214685

NOVEL MUTATIONS AND TRANSLOCATIONS INVOLVING NUCLEOPHOSMIN (NPM1) GENE IN ACUTE MYELOID LEUKEMIA (AML) AND LEADING TO ABERRANT CYTOPLASMIC NPM1

EHA Library, Maria Paola Martelli, 214686

THE LSC17 SCORE ALLOWS RISK STRATIFICATION IN PEDIATRIC ACUTE MYELOID LEUKEMIA

EHA Library, Nicolas Duployez, 214687

MUTATION PROFILE AND BENEFIT OF GEMTUZUMAB OZOGAMICIN IN ACUTE MYELOID LEUKEMIA PATIENTS TREATED IN THE ALFA-0701 TRIAL

EHA Library, Elise Fournier, 214688

MOLECULAR PATHOGENESIS OF DISEASE PROGRESSION IN MLL-REARRANGED AML

EHA Library, Hideki Makishima, 214689

GENOMIC CHARACTERISTICS OF ACUTE ERYTHROID LEUKEMIA

EHA Library, June Takeda, 214690

FUNCTIONAL PROTEOMICS ANALYSIS OF AML-RELATED NUP98-FUSION PROTEIN INTERACTOMES

EHA Library, Stefan Terlecki-Zaniewicz, 214691

THE PNT DOMAIN OF ERG REGULATES HEMATOPOIETIC STEMNESS, YET IS NOT ESSENTIAL FOR ERG INDUCED ACUTE MYELOID LEUKEMIA

EHA Library, Eitan Kugler, 214692

FUNCTIONAL ANALYSIS OF EPIGENETIC AND TRANSCRIPTOMIC EFFECTS OF CEBPA MUTATIONS IN ACUTE MYELOID LEUKEMIA

EHA Library, Elizabeth Heyes, 214693

DETECTION OF MEASURABLE RESIDUAL DISEASE (MRD) BY ULTRADEEP NEXT GENERATION SEQUENCING (NGS) IS HIGHLY PREDICTIVE OF OUTCOME IN NPM1 MUTATED ACUTE MYELOID LEUKEMIA (AML)

EHA Library, Nikhil Patkar, 214694

PREFERENTIAL IN VITRO AND IN VIVO INDUCTION OF ENDOGENOUS RETROVIRUS TRANSCRIPTION FROM A MONOALLELIC CHROMOSOME 7Q IN DECITABINE (DAC) TREATED AML BLASTS

EHA Library, Gabriele Greve, 214695

NOVEL DEEP TARGETED SEQUENCING METHOD FOR MINIMAL RESIDUAL DISEASE MONITORING IN ACUTE MYELOID
 LEUKEMIA

EHA Library, Maria Esther Onecha Fuente, 214696

A SYSTEMATIC EVALUATION OF PROGNOSTIC GENE EXPRESSION SIGNATURES IN 1208 ACUTE MYELOID LEUKEMIA PATIENTS REVEALS NOVEL INSIGHTS FOR FUTURE RESEARCH AND CLINICAL APPLICATION

EHA Library, Dominik Beck, 214697

AN ARTIFICIAL NEURAL NETWORK-BASED APPROACH IDENTIFIES A POWERFUL 3-GENE PREDICTOR OF ADVERSE PROGNOSIS IN ACUTE MYELOID LEUKAEMIA

EHA Library, Sarah Wagner, 214698

PROFILING AND FUNCTIONAL ANALYSIS OF CIRCULAR RNAS IN ACUTE PROMYELOCYTIC LEUKEMIA AND THEIR DYNAMIC REGULATION DURING ALL-TRANS RETINOIC ACID TREATMENT

EHA Library, Shufen Li, 214699

PML-RARA INTERACTS WITH NRF2, INHIBITS ITS ACTIVITY AND INCREASES THE SENSITIVITY OF ACUTE PROMYELOCITIC LEUKEMIA CELLS TO ASCORBATE

EHA Library, Nelida Ines Noguera, 214700

INTEGRATIVE ANALYSIS OF GENOMIC DATA REPOSITIONS THE USE OF 5’-AZACYTIDINE AND DECITABINE IN BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM TREATMENT

EHA Library, Maria Rosaria Sapienza, 214630

FUNCTIONAL EVALUATION AND MECHANISM RESEARCH OF KEL AND CIRC-KEL IN AEL

EHA Library, Hui Jin, 214702

MOLECULAR PROFILES IN AML PATIENTS OLDER THAN 70 YEARS OF AGE

EHA Library, Montserrat Hoyos Colell, 214704

COMPARISON OF WHOLE GENOME ANALYSIS APPROACHES FOR DETECTION OF MAJOR CHROMOSOMAL ABERRATIONS USING A DIVERSE SET OF LEUKEMIA PATIENTS

EHA Library, Sven Twardziok, 214705

SOMATIC MUTATIONS IN RELAPSED ACUTE MYELOID LEUKEMIA

EHA Library, Samuli Eldfors, 214706

EXPRESSION OF PIWI-INTERACTING RNAS (PIRNAS) AND ITS PROGNOSTIC IMPLICATION IN ACUTE MYELOID LEUKEMIA (AML): A 3-PIRNA SCORING SYSTEM PREDICTS PROGNOSIS IN AML PATIENTS

EHA Library, Ta-Chuan Yu, 214707

BASOPHIL-LINEAGE COMMITMENT IN ACUTE PROMYELOCYTIC LEUKEMIA PREDICTS FOR SEVERE BLEEDING AFTER STARTING THERAPY

EHA Library, Alberto Orfao, 214708

RECURRENCE OF THE 8Q24 REARRANGEMENT IN BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM AND ITS ASSOCIATION WITH IMMUNOBLASTOID CYTOMORPHOLOGY, MYC EXPRESSION, AND DRUG RESPONSE

EHA Library, Kana Sakamoto, 214709

COMBINATION OF FLT3 INHIBITOR QUIZARTINIB AND MDM2 INHIBITOR MILADEMETAN RESULTS IN GREATER PRE-CLINICAL ANTI-LEUKEMIC ACTIVITY IN FLT3-ITD MUTANT/P53 WILD-TYPE ACUTE MYELOID LEUKEMIA MODELS

EHA Library, Michael Andreeff, 214710

A GROUP OF EMA-APPROVED IMMUNOMODULATORS TARGETS AML STEM CELLS BY SABOTAGING THE CELLULAR RECYCLING MACHINERY

EHA Library, Josep Maria CORNET MASANA, 214711

EXPLORING ALTERNATIVE TREATMENTS TO IMPROVE OUTCOME FOR PEDIATRIC PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Katrina Lappin, 214712

ADDITION OF CRENOLANIB TO STANDARD INDUCTION AND CONSOLIDATION THERAPIES IMPROVED LONG-TERM OUTCOMES IN NEWLY DIAGNOSED FLT3-MUTANT AML PATIENTS ≤ 60 YEARS OLD

EHA Library, Roland B. Walter, 214713

COMBINATION OF IDARUBICIN, CYTARABINE AND CLADRIBINE AS INDUCTION REGIMEN FOR UNTREATED ADULT AML AGED 60 OR YOUNGER: A PHASE III RANDOMIZED CLINICAL TRIAL

EHA Library, Jia Chen, 214714

REASSESSING THE PROGNOSTIC SIGNIFICANCE OF RECURRING CHROMOSOMAL ABNORMALITIES AND FLT3-ITD IN ACUTE MYELOID LEUKEMIA PATIENTS UNDERGOING ALLOGENEIC STEM CELL TRANSPLANTATION: AN ALWP/EBMT ANALYSIS

EHA Library, Jonathan Canaani, 214715

DECITABINE IN DAY TO DAY PRACTICE IN UNTREATED AML, RISK FACTORS AND COMPARISON WITH DACO16

EHA Library, Adolfo De La Fuente, 214717

INITIAL PHASE 1 RESULTS OF THE FIRST-IN-CLASS ANTI-CD47 ANTIBODY HU5F9-G4 IN RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA PATIENTS

EHA Library, Paresh Vyas, 214718

IMPACT OF CONCOMITANT EXPRESSION OF CD200 AND BCL2 ON OUTCOME OF ACUTE MYELOID LEUKEMIA

EHA Library, Mario Tiribelli, 214719

TP53 MUTATIONS NEGATIVELY IMPACT SURVIVAL OF ACUTE MYELOID LEUKEMIA PATIENTS TREATED WITH STANDARD DOSES OF HYPOMETHYLATING AGENTS

EHA Library, Pierre Bories, 214720

CHARACTERISTICS AND OUTCOME OF PATIENTS WITH ACUTE MYELOID LEUKEMIA AND T(8;16)(P11;P13): RESULTS FROM AN INTERNATIONAL COLLABORATION

EHA Library, Sabine Kayser, 214721

A PHASE 1 DOSE ESCALATION STUDY OF THE IDH1M INHIBITOR, FT-2102, IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) OR MYELODYSPLASTIC SYNDROME (MDS)

EHA Library, Maria Baer, 214722

RISK FACTORS IN RELAPSE/REFRACTORY AML TREATED WITH DECITABINE

EHA Library, Adolfo De La Fuente, 214723

SAFETY AND PHARMACOKINETICS OF A NOVEL ORAL CAPSULE FORMULATION OF ARSENIC TRIOXIDE, ORH-2014, IN PATIENTS WITH ADVANCED HEMATOLOGIC DISORDERS

EHA Library, Farhad Ravandi-Kashani, 214724

OUTCOMES BY NUMBER OF INDUCTION CYCLES WITH CPX-351 VERSUS 7+3 CHEMOTHERAPY IN OLDER ADULTS WITH NEWLY DIAGNOSED, HIGH-RISK/SECONDARY ACUTE MYELOID LEUKEMIA (SAML)

EHA Library, Jorge Cortes, 214725

POST HOC EXPLORATORY ANALYSIS OF TWO PHASE 2 TRIALS OF QUIZARTINIB MONOTHERAPY IN PATIENTS WITH FLT3-ITD MUTATED RELAPSED/REFRACTORY AML AND PRIOR FLT3 TYROSINE KINASE INHIBITOR TREATMENT

EHA Library, Jorge Cortes, 214726

RISK FACTORS OF EARLY DEATH FOR PATIENTS WITH NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA UNDER THE TREATMENT OF ATRA, ATO WITH OR WITHOUT CHEMOTHERAPY

EHA Library, Li Chen, 214728

PHASE II STUDY INCORPORATING A NOVEL BH3-PROFILING BIOMARKER APPROACH OF ALVOCIDIB FOLLOWED BY CYTARABINE AND MITOXANTRONE IN RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (AML)

EHA Library, Joshua F. Zeidner, 214729

OUTCOME OF A REAL-LIFE POPULATION OF ACUTE PROMYELOCYTIC LEUKEMIA TREATED ACCORDING TO PETHEMA LPA 2005 PROTOCOL: THE POLISH ADULT LEUKEMIA GROUP (PALG) EXPERIENCE.

EHA Library, Marta Sobas, 214730

GLASDEGIB IMPROVED OVERALL SURVIVAL IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) OR MYELODYSPLASTIC SYNDROME (MDS) WHO ACHIEVED COMPLETE REMISSION (CR) AND THOSE WHO DID NOT ACHIEVE CR

EHA Library, Jorge Cortes, 214731

HIGH COMPLETE REMISSION RATES WITH ORAL SYK INHIBITOR ENTOSPLETINIB (GS-9973) IN ACUTE MYELOID LEUKEMIA PATIENTS ASSOCIATED WITH HIGH HOXA9/MEIS1 EXPRESSION.

EHA Library, Veerendra Munugalavadla, 214732

WEEKEND VERSUS WEEKDAY DIAGNOSIS AND EARLY MORTALITY IN ACUTE PROMYELOCYTIC LEUKEMIA: A POPULATION-BASED ANALYSIS IN THE NETHERLANDS

EHA Library, Avinash Dinmohamed, 214733

DECITABINE IN PATIENTS WITH NEWLY DIAGNOSED AND RELAPSED ACUTE MYELOID LEUKEMIA (AML): THE REAL LIFE EXPERIENCE FROM THE “ITALIAN TRIVENETO REGISTRY”.

EHA Library, Carla Fili, 214734

PROGNOSTIC IMPACT OF SKELETAL MUSCLE ASSESSED BY COMPUTED TOMOGRAPHY SCAN IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Nobuhiko Nakamura, 214735

INCIDENCE OF MARROW NEOPLASMS IN BREAST CANCER SURVIVORS: A NATIONAL POPULATION-BASED COHORT STUDY

EHA Library, Norbert Vey, 214736

WILMS TUMOR 1 EXPRESSION IN ACUTE MYELOID LEUKEMIA CORRELATES WITH CYTOGENETICS OR COLLABORATIVE MUTATIONS: HOKKAIDO LEUKEMIA NET STUDY

EHA Library, Daisuke Hidaka, 214737

OUTCOMES FOR T(9;11) PATIENTS ARE NO BETTER THAN FOR OTHER REARRANGEMENT PARTNERS IN 11Q23-REARRANGED ADULT AML: A COMPREHENSIVE REVIEW OF MLL-R AML TREATED AT MEMORIAL SLOAN KETTERING CANCER CENTER

EHA Library, Kamal Menghrajani, 214738

HYPOMETILATING AGENTS (HMA) AS SALVAGE THERAPY IN RELAPSED OR REFRACTORY AML: AN ITALIAN 9-CENTER RETROSPECTIVE STUDY

EHA Library, Marica Laurino, 214739

COMPREHENSIVE ANALYSIS OF THE CORE-BINDING FACTOR ACUTE MYELOID LEUKEMIA WITH KOREAN AML REGISTRY

EHA Library, Ho-Jin Shin, 214740

TARGETING WNT10B*R-MEDIATED AUTOCRINE WNT SIGNALING ACTIVATION IN ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Adriana Cassaro, 214663

DEHYDROPEPTIDASE 1 ENHANCED THE GROWTH AND SURVIVAL OF LEUKEMIA CELLS IN VIVO AND IDENTIFIED A HIGH RISK OF RELAPSE IN PATIENTS WITH COMMON B-CELL ALL

EHA Library, Jiamin Zhang, 214662

NOVEL TARGETED THERAPIES FOR RESISTANT CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Sanil Bhatia, 214661

ENHANCED EFFICACY OF THE SYK INHIBITOR ENTOSPLETINIB AND VINCRISTINE IN KMT2A-REARRANGED ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Sarah Tasian, 214660

INTEGRATED GENETIC AND EPIGENETIC ANALYSIS ELUCIDATED EXPRESSION AND METHYLATION PROFILES OF ACUTE LYMPHOBLASTIC LEUKEMIA IN DOWN SYNDROME

EHA Library, Yasuo Kubota, 214659

CIRCULAR RNAOME VARIATION IN NORMAL HEMATOPOIESIS AND MLL REARRANGED ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Stefania Bortoluzzi, 214658

CDK8 DEGRADATION - PREPARING THE GROUND FOR MTOR INHIBITION IN BCR/ABL+ ALL

EHA Library, Ingeborg Menzl, 214657

IDENTIFYING NEW DISEASE GENES IN FAMILIAL MYELODYSPLASIA/ACUTE MYELOID LEUKEMIA

EHA Library, Ana Rio-Machin, 214650

COMBINATORIAL CSF3R AND RUNX1 MUTATIONS INVOLVED IN THE LEUKEMIC PROGRESSION OF SEVERE CONGENITAL NEUTROPENIA CONFER A G-CSF-DEPENDENT PREMALIGNANT STATE IN MICE TERMINATING IN G-CSF INDEPENDENT AML

EHA Library, Patricia Olofsen, 214649

EPIGENOMIC ANALYSIS REVEALS STEM CELL-LIKE RELAPSE SIGNATURE IN PEDIATRIC ACUTE MYELOID LEUKEMIA

EHA Library, Caroline Wiggers, 214648

5-AZACYTIDINE ENHANCES THE ANTI-LEUKEMIC ACTIVITIY OF IDH1 INHIBITOR BAY 1436032 IN VIVO IN IDH1 MUTANT ACUTE MYELOID LEUKEMIA

EHA Library, Anuhar Chaturvedi, 214632

LOSS OF TET2 FOLLOWED BY ACQUISITION OF ACTIVATING KRAS MUTATION LEADS TO COOPERATIVE MALIGNANT MYELOPROLIFERATION THROUGH AMPLIFICATION OF RAS SIGNALING IN A DOSE- AND TIME-DEPENDENT MANNER

EHA Library, Matthew Miller, 214631

A POSSIBLE FIRST TIER SCREENING TEST TO DETECT TRANSLOCATIONS IN LEUKEMIAS USING TARGETED LOCUS AMPLIFICATION

EHA Library, Eva Van Den Berg-De Ruiter, 214701